Aug 4, 2026 07:38AM
Aug 4, 2026 07:30AM
May 7, 2026 07:39AM
Apr 9, 2026 07:31AM
Apr 9, 2026 07:30AM
Feb 27, 2026 07:30AM
Feb 23, 2026 08:17AM ImmunityBio, Inc. (IBRX) Tops Q4 EPS by 5c
Feb 23, 2026 07:01AM
Feb 23, 2026 07:00AM
Jan 15, 2026 08:41AM
Jan 15, 2026 08:32AM
Jan 15, 2026 08:30AM
Nov 5, 2025 01:58AM
Nov 4, 2025 10:12PM Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434% from Q3 2024
Aug 5, 2025 07:31AM
Aug 5, 2025 07:00AM
Jul 25, 2025 06:00AM
May 12, 2025 06:36AM
May 12, 2025 06:30AM
Apr 15, 2025 08:01AM
Apr 15, 2025 08:00AM ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia
Mar 3, 2025 04:23PM
Mar 3, 2025 07:30AM
Nov 12, 2024 04:33PM
Nov 12, 2024 07:15AM
Mar 25, 2024 08:21AM
Jul 21, 2023 09:00PM
Jul 16, 2023 08:58PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Arrow Financial, ImmunityBio, Seagate, and Baxter and Encourages Investors to Contact the Firm
Nov 17, 2022 09:00AM
Nov 8, 2021 04:11PM
Mar 15, 2021 09:09AM

1,217,868 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All